71
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2016
Study Completion Date
November 30, 2016
continuous infusion of levobupivacaine
continuous infusion of levobupivacaine 0,125% at 5 ml/h , bolus dose 6 ml, lock out 30 minutes 4 hours limit: 60 ml/h
Intermittent bolus infusion of levobupivacaine
Intermittent bolus of levobupivacaine 0,125%: 0.1 ml /h and 9,8 ml bolus every two hours. Optional patient controlled bolus dose 6 ml, lock out 30 minutes, 4 hours limit: 60 ml/h
University Hospital Antwerp, Antwerp
University Hospital, Antwerp
OTHER